$2.30
0.177.98%
Last update: Nov 6, 4:44 PM
Protara Therapeutics Inc (TARA) Stock Price, Quote, News & History
TARANASDAQ
Protara reports updated Phase 2 data showing durable responses and favorable safety for TARA-002 in bladder cancer patients.
You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.
Other companies in Protara Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Protara Therapeutics has a consensus price target of $22.64.
The stock price for Protara Therapeutics (NASDAQ: TARA) is $2.27 last updated November 6, 2026 at 4:44 PM EST.
There are no upcoming dividends for Protara Therapeutics.
Protara Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Protara Therapeutics.
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development...
